Plant ID: NPO2722
Plant Latin Name: Humulus japonicus
Taxonomy Genus: Humulus
Taxonomy Family: Cannabaceae
NCBI TaxonomyDB:
3485
Plant-of-the-World-Online:
n.a.
Diuretic; Tonic
China
TDP1; GFER; ALDH1A1; HSD17B10; POLB; | |
TRPA1; | |
CA2; CA7; CA12; CA9; | |
PTGS1; | |
CASP7; CASP1; | |
L3MBTL1; SMN1;SMN2; | |
LMNA; |
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Methyl-lysine/arginine binding protein | L3MBTL1 | Lethal(3)malignant brain tumor-like protein 1 | Q9Y468 | CHEMBL1287622 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 7.157E-10 | 1.559E-05 | CA12, CA2, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.051E-08 | 2.215E-04 | CA12, CA2, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 6.999E-08 | 3.810E-04 | CA12, CA2, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 2.459E-06 | 7.650E-03 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.085E-09 | 4.231E-08 | CA12, CA2, CA7, CA9 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.104E-03 | 1.991E-02 | CASP7, CASP1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.539E-03 | 1.991E-02 | CYP1A2, ALDH1A1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 2.042E-03 | 1.991E-02 | CASP7, CASP1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 6.916E-03 | 4.496E-02 | CASP7, LMNA |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 9.825E-03 | 5.010E-02 | CASP7, HSD17B10 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 1.028E-02 | 5.010E-02 | SMN2, SMN1 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 2.403E-02 | 8.382E-02 | CA2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.579E-02 | 8.382E-02 | CYP1A2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 4.492E-03 | 3.504E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
NA: NA | Edema | NA | CA2; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |